Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations

Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold 4,169 shares of common stock on February 24, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 24, 2025, Gina Mazzariello, the Chief Legal Officer of Amylyx Pharmaceuticals, sold 4,169 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $3.153, with individual transactions ranging from $3.14 to $3.18.
• Following the transaction, Mazzariello directly owns 134,921 shares of Amylyx Pharmaceuticals.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (sale of shares for tax obligations) by a company executive, which is neither particularly positive nor negative.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of the company's performance or future prospects.

Key Dates